- Home
- GH vs DD Comparison
GH vs DD Comparison
Compare GH & DD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GH | DD |
|---|---|---|
| Founded | 2011 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.3B | 20.2B |
| IPO Year | 2018 | 2016 |
Fundamental Metrics
Financial Performance| Metric | GH | DD |
|---|---|---|
| Price | $131.72 | $47.97 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 12 |
| Target Price | ★ $119.79 | $56.67 |
| AVG Volume (30 Days) | ★ 2.4M | 2.2M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 1.79% |
| EPS Growth | ★ 6.74 | N/A |
| EPS | N/A | ★ 0.39 |
| Revenue | $982,021,000.00 | ★ $20,397,000,000.00 |
| Revenue This Year | $33.30 | $6.72 |
| Revenue Next Year | $28.27 | $3.83 |
| P/E Ratio | ★ N/A | $123.14 |
| Revenue Growth | ★ 32.88 | N/A |
| 52 Week Low | $40.36 | $33.34 |
| 52 Week High | $135.00 | $83.40 |
Technical Indicators
Market Signals| Indicator | GH | DD |
|---|---|---|
| Relative Strength Index (RSI) | 65.11 | 49.93 |
| Support Level | $122.76 | $45.17 |
| Resistance Level | $134.28 | $48.15 |
| Average True Range (ATR) | 6.05 | 1.33 |
| MACD | -1.11 | 0.04 |
| Stochastic Oscillator | 71.83 | 59.29 |
Price Performance
Historical ComparisonAbout GH Guardant Health Inc.
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About DD DuPont de Nemours Inc.
DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the healthcare, water, construction, automotive, aerospace, and printing and packaging industries. Healthcare and water will generate the majority of profits.